YUHUA XIAO: Open Payments
NPI 1467861237 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$848 in 23 payments from 10 companies in 2025. Trend: 2023 $485 · 2024 $582 · 2025 $848
Food & beverage: $648Education: $200
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $357 |
| Incyte Corporation | 4 | $115 |
| AstraZeneca Pharmaceuticals LP | 3 | $99 |
| SOBI, INC | 2 | $65 |
| Syndax Pharmaceuticals, Inc. | 2 | $61 |
| TAIHO ONCOLOGY, INC. | 1 | $35 |
| Celgene Corporation | 1 | $34 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| ABBVIE INC. | 1 | $33 |
| Lilly USA, LLC | 1 | $15 |
Products named: Cresemba, JAKAFI, CALQUENCE, INQOVI, Vonjo, REBLOZYL, IMBRUVICA, Xospata.
Industry payments across TX — which companies pay providers there.
